Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Other

Amber photobiomodulation versus tranexamic acid for the treatment of melasma: protocol for a double-blind, randomised controlled trial

The results obtained in this trial will be presented at conferences and submitted for publication. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov Registry (NCT05326997).

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This protocol describes a planned randomised, double-blind trial comparing amber photobiomodulation at 590 nm with liposomal tranexamic acid for facial melasma in 54 women. The authors report that results have not yet been obtained, so no efficacy finding is available from this paper.

Participants
54
Who or what was studied
Women aged 35-50 years with facial melasma and skin phototypes II-IV, planned for 54 participants at two centres in Sao Paulo State, Brazil.
Wavelengths
590 nm
Limits stated in the abstract
This is a study protocol only, so no outcome data are reported, and the abstract does not describe any results.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.

Record from PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
590 nm

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Intention-to-treat analysis, Trial registration, Primary outcome, Melanin, Sham. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies